Wang, Qian <br/><br/>
Lipoxin A(4) activates alveolar epithelial sodium channel, Na,K-ATPase, and increases alveolar fluid clearance.  [electronic resource] 

 -  American journal of respiratory cell and molecular biology  May 2013 
 - 610-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-4989 
<br/><br/><label>Standard No.: </label>10.1165/rcmb.2012-0274OC  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Lung Injury--drug therapy<br/>Alveolar Epithelial Cells--drug effects<br/>Animals<br/>Cells, Cultured<br/>Cyclic AMP--metabolism<br/>Cyclic GMP--metabolism<br/>Epithelial Sodium Channel Agonists--administration & dosage<br/>Epithelial Sodium Channel Blockers--pharmacology<br/>Epithelial Sodium Channels--genetics<br/>Gene Expression--drug effects<br/>Heptanoic Acids--pharmacology<br/>Lipopolysaccharides--pharmacology<br/>Lipoxins--administration & dosage<br/>Male<br/>Mucociliary Clearance<br/>Oligopeptides--pharmacology<br/>Peroxidase--metabolism<br/>Pulmonary Alveoli--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Sodium-Potassium-Exchanging ATPase--metabolism<br/>Tumor Necrosis Factor-alpha--metabolism